Vipan Kumar

31PUBLICATIONS
13CO-AUTHORS
Biologically active moleculesBiomolecular modelling and designCheminformatics and quantitative structure-activity relationshipsMolecular targetsFoetal development and medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Aug 31, 2026
Recent Developments in Triazolopyrimidine-based Cancer Therapeutics: A Mini Review.

|Aug 06, 2026
Dihydropyrimidinone-isatin hybrids as potent inducers of cell-cycle arrest and caspase-dependent apoptosis in MV4-11 acute myeloid leukemia cells.

|Jul 09, 2026
4-Aminoquinoline derivatives and benzoxaborole-4-aminoquinoline hybrids: synthesis, antiplasmodial evaluation, heme-inhibition and in silico studies.

|Apr 10, 2026
Triclosan-isatin hybrids as potent anti-proliferative agents inducing S-phase arrest via DNA gyrase inhibition in triple-negative breast cancer.

Shekhar, Asif Raza, Sukhmanpreet Kaur

|Aug 14, 2025
Design, Synthesis, and Biological Evaluation of Triazolopyrimidine-Isatin Hybrids as Promising Candidates for Triple-Negative Breast Cancer.

Shefali Chowdhary, Asif Raza, Natacha Henry

|Aug 06, 2025
Design, synthesis, and anti-plasmodial profiling of oxalamide-linked 4-aminoquinoline-phthalimide hybrids.

Nikita Gupta, Kewal Kumar, Raghu Raj

Pageof 6

Frequent Collaborators

3 joint publications

Raghu Raj

3 joint publications

Asif Raza

2 joint publications

Pascal Roussel

1 joint publications

Paul Awolade